Edit
Business Wire17 Feb 2014
DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/7r67r9/tinnitus) has announced the addition of the "Tinnitus - Pipeline Review, H2 2013" report to their offering. 'Tinnitus - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline ... It also reviews key players involved in the therapeutic development for Tinnitus. Scope ... ... esketamine hydrochloride - Drug Profile ... ....(size: 5.1Kb)
Edit
National Public Radio07 Jun 2013
When it comes to profound depression, many people just can't get relief from current treatments ... Doctors at the Mayo Clinic gave 10 patients ketamine twice a week as an infusion that lasted 100 minutes ... Timothy W ... Johnson & Johnson's Janssen drug division has been testing ketamine infusions and a derivative called esketamine that can be taken through the nose ... At a , the company said early esketamine results looked "promising." ... ....(size: 2.8Kb)
Edit
Fox News24 May 2013
iStock ... The intranasal drug, called esketamine, is closely related to a pediatric anesthetic called ketamine that has been shown in academic studies to ease symptoms rapidly in such patients, including a reduction in suicidal thoughts ... Manji said esketamine could be very important for depressed patients who have become suicidal, because it works so quickly ... The Yale research shows ketamine takes effect within hours ... Share This Article. ....(size: 4.3Kb)
Edit
PhysOrg23 May 2013
Another of the 11 drugs is esketamine, which is chemically related to ketamine, an anesthetic sometimes abused at raves for the high and hallucinations it can produce. J&J; this year started mid-stage patient testing of an inhaled, low-dose version of esketamine for patients not helped by other antidepressants....(size: 4.1Kb)
Edit
Seattle Post23 May 2013
Another of the 11 drugs is esketamine, which is chemically related to ketamine, an anesthetic sometimes abused at raves for the high and hallucinations it can produce. J&J this year started mid-stage patient testing of an inhaled, low-dose version of esketamine for patients not helped by other antidepressants....(size: 4.5Kb)
